ARTICLE | Company News
Isis Pharmaceuticals, GlaxoSmithKline deal
March 10, 2014 7:00 AM UTC
Isis received a $1 million milestone payment from GlaxoSmithKline under a 2010 deal to discover and develop up to six therapeutics using Isis' antisense technology against rare and serious diseases, i...